Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 38.76
+0.57 (1.49%)
Jan 23, 2026, 10:10 AM CST
SHA:688639 Market Cap
SHA:688639 has a market cap or net worth of 9.52 billion as of January 22, 2026. Its market cap has increased by 29.00% in one year.
Market Cap
9.52B
Enterprise Value
11.11B
Revenue
2.83B
Ranking
n/a
PE Ratio
50.29
Stock Price
38.76
Market Cap Chart
Since April 22, 2021, SHA:688639's market cap has increased from 3.81B to 9.52B, an increase of 150.18%. That is a compound annual growth rate of 21.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 9.50B | 16.97% |
| Dec 31, 2025 | 8.13B | 10.70% |
| Dec 31, 2024 | 7.34B | -62.99% |
| Dec 29, 2023 | 19.83B | 17.86% |
| Dec 30, 2022 | 16.83B | 20.56% |
| Dec 31, 2021 | 13.96B | 266.67% |
| Apr 22, 2021 | 3.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 10.54B |
| Chengdu Easton Biopharmaceuticals | 10.24B |
| Acrobiosystems | 10.16B |
| Bio-Thera Solutions | 10.12B |
| Chengzhi | 10.11B |
| Chengdu Kanghua Biological Products | 9.93B |
| Sino Biological,Inc. | 9.29B |
| Jiangxi Fushine Pharmaceutical | 9.14B |